Skip to Main Content
Skip Nav Destination

There is a considerable body of legislation governing the regulation of human medicinal products in the European Union. This legislation has evolved over the last fifty years, and it continues to evolve. The legislation is supported where necessary by scientific guidelines, including guidelines concerning safety aspects of medicines. The evaluation of human medicines is conducted through expert committees and subsidiary groups which cover all aspects of quality, safety and efficacy. This chapter discusses the evaluation of human medicinal products and the processes that lead to them gaining access to the commercial market, as well as the processes in place to ensure that marketed products continue to be monitored once in use.

You do not currently have access to this chapter, but see below options to check access via your institution or sign in to purchase.
Don't already have an account? Register
Close Modal

or Create an Account

Close Modal
Close Modal